Abstract
Purpose: Determine if estrogen used since the beginning of the menstrual flow could improve endometrial tissue compared to standard endometrial preparation for in vitro maturation cycles.
Methods: Twenty polycystic ovary syndrome women were submitted to two estrogen therapy schedules: standard schedule; estrogen began on the day of planned egg retrieval (dosage was based on endometrial thickness); and long schedule; estrogen began on the first day of menstruation. No oocyte retrieval or embryo transfer was performed. Three-dimensional ultrasound was performed on the day of planned egg retrieval and one week later for endometrial evaluation.
Results: A higher endometrial thickness and volume was found in long schedule on both evaluations. The number of patients that have used 10 mg/day of estradiol was significant higher in the standard schedule (65%×0%). No other significant difference was found.
Conclusions: The early use of estrogen improves endometrial tissue and requires lower daily dosage.
Similar content being viewed by others
References
Engmann L, Maconochie N, Bekir JS, Jacobs HS, Tan SL. Cumulative probability of clinical pregnancy and live birth after a multiple cycle IVF package: A more realistic assessment of overall and age-specific success rates? Br J Obstet Gynaecol 1999;106:165–170
Trounson A, Wood C, Kausche A. In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril 1994;62:353–362
Cha KY, Han SY, Chung HM, Choi DH, Lim JM, Lee WS, et al. Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome. Fertil Steril 2000;73:978–983
Chian RC, Buckett WM, Tulandi T, Tan SL. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod 2000;15:165–170
Mikkelsen AL, Smith S, Lindenberg S. Impact of oestradiol and inhibin a concentrations on pregnancy rate in in-vitro oocyte maturation. Hum Reprod 2000;15:1685–1690
Shamonki MI, Spandorfer SD, Rosenwaks Z. Ultrasound-guided embryo transfer and the accuracy of trial embryo transfer. Hum Reprod 2005;20:709–716
Le Du A, Kadoch IJ, Bourcigaux N, Doumerc S, Bourrier MC, Chevalier N, et al. In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience. Hum Reprod 2005;20:420–424
Soderstrom-Anttila V, Makinen S, Tuuri T, Suikkari AM. Favourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients. Hum Reprod 2005;20:1534–1540
Kovacs P, Matyas S, Boda K, Kaali SG. The effect of endometrial thickness on IVF/ICSI outcome. Hum Reprod 2003;18:2337–2341
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;1:41–47
Schild RL, Holthaus S, d’Alquen J, Fimmers R, Dorn C, van Der Ven H, et al. Quantitative assessment of subendometrial blood flow by three-dimensional ultrasound is an important predictive factor of implantation in an in-vitro fertilization programme. Hum Reprod 2000;15:89–94
Gosling RG, Dunbar G, King DH, Newman DL, Side CD, Woodcock JP, et al. The quantitative analysis of occlusive peripheral arterial disease by non-intrusive ultrasound technique. Angiology 1971;22:52–55
Pourcelot L. Applications cliniques de l’examen Doppler transcutane. In: Peronneau P, editor. Velocimetrie ultrasonore Doppler. Serminaire INSERM, Paris 1974;34:213–240
Raine-Fenning N, Campbell B, Collier J, Brincat M, Johnson I. The reproducibility of endometrial volume acquisition and measurement with the VOCAL-imaging program. Ultrasound Obstet Gynecol 2002;19:69–75
Yaman C, Ebner T, Sommergruber M, Polz W, Tews G. Role of three-dimensional ultrasonographic measurement of endometrium volume as a predictor of pregnancy outcome in an IVF-ET program: a preliminary study. Fertil Steril 2000;74:797–801
Croxatto HB, Diaz S, Fuentealba BA, Croxatto HD, Carrilo D, Fabres C. Studies on the duration of egg transport in the human oviduct: the time interval between ovulation and egg recovery from the uterus in normal women. Fertil Steril 1972;23:447–458
Norwitz ER, Schust DJ, Fisher SJ. Implantation and survival of the early pregnancy. N Engl J Med 2001;345:1400–1408
Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. New Engl J Med 1999;340:1796–1799
Giudice LC. Potential biochemical markers of uterine receptivity. Hum Reprod 1999;14(Suppl 2):3–16
Navot D, Anderson T, Droesch K. Hormonal manipulation of endometrial maturation. J Clin Endocrionl Metab 1989;68:81–87
Yaron Y, Amit A, Mani A, Yovel I, Kogosowski A, Peyser MR, et al. Uterine preparation with estrogen for oocyte donation: assessing the effect of treatment duration on pregnancy rates. Fertil Steril 1995;63:1284–1286
Leeton J, Rogers P, Healy D. A comparison of pregnancy rates for 131 donors oocyte transfers using either a sequential or fixed regime of steroid replacement therapy. Hum Reprod 1991;6:299–301
Navot D, Bergh PA, Williams M, Garrisi GJ, Guzman I, Sandler B, et al. An insight into early reproductive processes through the in vivo model of ovum donation. J Clin Endocrinol Metab 1991;72:408–414
Tang B, Gurpide E. Direct effect of gonadotropins on decidualization of human endometrial stroma cells. J Steroid Biochem Mol Biol 1993;47:115–121
Licht P, Losch A, Dittrich R, Neuwinger J, Siebzehnrubl E, Wildt L. Novel insights into human endometrial paracrinology and embryo-maternal communication by intra-uterine microdialysis. Hum Reprod Update 1998;4:532–538
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martins, W.d.P., Reis, R.M.d., Ferriani, R.A. et al. Endometrial preparation for in vitro oocyte maturation: Early use of estrogen increases endometrial tissue and requires lower daily dosage: A cross over trial in ‘mock’ cycles. J Assist Reprod Genet 23, 241–246 (2006). https://doi.org/10.1007/s10815-006-9042-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-006-9042-4